IZAR CAPITAL SELECTED TO REPRESENT
SELLING SHAREHOLDER GROUP OF
SPECIALIZED GLOBAL LAB SERVICES ORGANIZATION
FOR SMALL AND MID-SIZED BIO-PHARMACEUTICAL COMPANIES
WASHINGTON, DC (October, 2018)
Izar Capital Selected To Represent Selling Shareholder Group Of Specialized Global Lab Services Organization
For Small And Mid-Sized Bio-Pharmaceutical Companies
Industry Sectors = Healthcare Services, Business Services, Biotech, Pharmaceutical
Geographies = USA, Latam, Europe, Asia
Oct, 2018
========================================
Izar Capital Group (“Izar Capital”), a specialized middle-market corporate finance advisory firm, has been selected to provide advisory services on selected corporate finance issues for the founders and selling shareholder group of a customized global central laboratory and support services to bio-pharmaceutical, medical device, and contract research organizations (“CRO”s), focused on small and mid-sized bio-pharmaceutical companies (the “Client”).
The Client focuses on managing clinical trials for small- and mid-sized bio-pharmaceutical companies, and serves as a bio-repository and provides specialized clinical collection kits, testing, tracking, data management bio-visualization, designs requisitions, creates training manuals, develops data transfer specifications, performs test validation, designs custom lab reports, assembles and ship customized clinical kits, and coordinates required testing with affiliate labs as needed.
Izar Capital’s hallmarks of excellence are grounded in critical-thinking, value-added insight and deal-based expertise in solving a wide variety of corporate finance and strategic growth challenges for middle-market companies in the U.S., Spain and Latin America.
Izar Capital Group (www.izarcapital.com)
Izar Capital Group, LLC is a middle-market focused, strategic advisory investment bank with expertise in Mergers and Acquisitions (buyside and sellside), Joint-Ventures and Partnerships, Private Debt and Equity Capital Advisory, as well as Corporate Strategic Advisory services. The firm operates globally, and has particular expertise within the U.S., as well as cross-border deals with Spain, Europe and Latin America. Creative problem solving, independent thinking and intellectual rigor are hallmarks of the Izar Capital process. Izar Capital professionals have completed over $18bn of transactions.
LabConnect (www.labconnectllc.com)
Founded in 2002, LabConnect provides global central laboratory services including routine and specialized laboratory testing, kit building, sample management, data management, bio-repository, and scientific support services for biopharmaceutical, medical device, and CRO clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs.
Izar Capital Selected To Represent Selling Shareholder Group Of Specialized Global Lab Services Organization
For Small And Mid-Sized Bio-Pharmaceutical Companies
Industry Sectors = Healthcare Services, Business Services, Biotech, Pharmaceutical
Geographies = USA, Latam, Europe, Asia
Oct, 2018
========================================
Izar Capital Group (“Izar Capital”), a specialized middle-market corporate finance advisory firm, has been selected to provide advisory services on selected corporate finance issues for the founders and selling shareholder group of a customized global central laboratory and support services to bio-pharmaceutical, medical device, and contract research organizations (“CRO”s), focused on small and mid-sized bio-pharmaceutical companies (the “Client”).
The Client focuses on managing clinical trials for small- and mid-sized bio-pharmaceutical companies, and serves as a bio-repository and provides specialized clinical collection kits, testing, tracking, data management bio-visualization, designs requisitions, creates training manuals, develops data transfer specifications, performs test validation, designs custom lab reports, assembles and ship customized clinical kits, and coordinates required testing with affiliate labs as needed.
Izar Capital’s hallmarks of excellence are grounded in critical-thinking, value-added insight and deal-based expertise in solving a wide variety of corporate finance and strategic growth challenges for middle-market companies in the U.S., Spain and Latin America.
Izar Capital Group (www.izarcapital.com)
Izar Capital Group, LLC is a middle-market focused, strategic advisory investment bank with expertise in Mergers and Acquisitions (buyside and sellside), Joint-Ventures and Partnerships, Private Debt and Equity Capital Advisory, as well as Corporate Strategic Advisory services. The firm operates globally, and has particular expertise within the U.S., as well as cross-border deals with Spain, Europe and Latin America. Creative problem solving, independent thinking and intellectual rigor are hallmarks of the Izar Capital process. Izar Capital professionals have completed over $18bn of transactions.
LabConnect (www.labconnectllc.com)
Founded in 2002, LabConnect provides global central laboratory services including routine and specialized laboratory testing, kit building, sample management, data management, bio-repository, and scientific support services for biopharmaceutical, medical device, and CRO clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs.